These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 10571771)

  • 61. Progression of chronic renal disease.
    Klahr S
    Heart Dis; 2001; 3(3):205-9. PubMed ID: 11975793
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Lowered intrarenal protein degradation--an alternative path to glomerulosclerosis and tubulo-interstitial fibrosis].
    Teschner M; Heidland A
    Med Klin (Munich); 2000 Jul; 95(7):385-91. PubMed ID: 10943099
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Proximal Tubulopathy: Prime Mover and Key Therapeutic Target in Diabetic Kidney Disease.
    Gilbert RE
    Diabetes; 2017 Apr; 66(4):791-800. PubMed ID: 28325740
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Kidney atrophy vs hypertrophy in diabetes: which cells are involved?
    Habib SL
    Cell Cycle; 2018; 17(14):1683-1687. PubMed ID: 29995580
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction.
    Chevalier RL
    Am J Physiol Renal Physiol; 2016 Jul; 311(1):F145-61. PubMed ID: 27194714
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The extracellular matrix in diabetic nephropathy.
    Ziyadeh FN
    Am J Kidney Dis; 1993 Nov; 22(5):736-44. PubMed ID: 8238022
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The renal tubulointerstitium in diabetes mellitus.
    Ziyadeh FN; Goldfarb S
    Kidney Int; 1991 Mar; 39(3):464-75. PubMed ID: 2062033
    [No Abstract]   [Full Text] [Related]  

  • 68. Growth factors in the pathogenesis of renovascular complications of diabetes mellitus.
    Woolf AS; Bosch RJ; Fine LG
    J Hypertens Suppl; 1992 Apr; 10(1):S11-6. PubMed ID: 1535654
    [TBL] [Abstract][Full Text] [Related]  

  • 69. High glucose instigates tubulointerstitial injury by stimulating hetero-dimerization of adiponectin and angiotensin II receptors.
    Zha D; Cheng H; Li W; Wu Y; Li X; Zhang L; Feng YH; Wu X
    Biochem Biophys Res Commun; 2017 Nov; 493(1):840-846. PubMed ID: 28870804
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tubular epithelial cell activation and interstitial fibrosis. The role of glomerular ultrafiltration of growth factors in the nephrotic syndrome and diabetic nephropathy.
    Wang SN; Hirschberg R
    Nephrol Dial Transplant; 1999 Sep; 14(9):2072-4. PubMed ID: 10489207
    [No Abstract]   [Full Text] [Related]  

  • 71. From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy.
    Qian Y; Feldman E; Pennathur S; Kretzler M; Brosius FC
    Diabetes; 2008 Jun; 57(6):1439-45. PubMed ID: 18511444
    [No Abstract]   [Full Text] [Related]  

  • 72. Novel tubular-glomerular interplay in diabetic kidney disease mediated by sirtuin 1, nicotinamide mononucleotide, and nicotinamide adenine dinucleotide Oshima Award Address 2017.
    Hasegawa K
    Clin Exp Nephrol; 2019 Aug; 23(8):987-994. PubMed ID: 30859351
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fibrogenic effects of cyclosporin A on the tubulointerstitium: role of cytokines and growth factors.
    Johnson DW; Saunders HJ; Johnson FJ; Huq SO; Field MJ; Pollock CA
    Exp Nephrol; 1999; 7(5-6):470-8. PubMed ID: 10559645
    [TBL] [Abstract][Full Text] [Related]  

  • 74. New Insights into the Pathogenesis of Diabetic Nephropathy: Proximal Renal Tubules Are Primary Target of Oxidative Stress in Diabetic Kidney.
    Haraguchi R; Kohara Y; Matsubayashi K; Kitazawa R; Kitazawa S
    Acta Histochem Cytochem; 2020 Apr; 53(2):21-31. PubMed ID: 32410750
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Interstitial fibrosis: tubular hypothesis versus glomerular hypothesis.
    Christensen EI; Verroust PJ
    Kidney Int; 2008 Nov; 74(10):1233-6. PubMed ID: 18974759
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High-glucose media enhance the responsiveness of tubular cells to growth promoters: effect on lysosomal cathepsins and protein degradation.
    Schenk O; Ling H; Sebeková K; Vamvakas S; Heidland A
    Miner Electrolyte Metab; 1998; 24(4):254-60. PubMed ID: 9554564
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Secreted protein acidic and rich in cysteine (SPARC) in patients with diabetic nephropathy and tubulointerstitial injury.
    Kanauchi M; Nishioka M; Dohi K
    Diabetologia; 2000 Aug; 43(8):1076-7. PubMed ID: 10990088
    [No Abstract]   [Full Text] [Related]  

  • 78. Identification and verification of vascular cell adhesion protein 1 as an immune-related hub gene associated with the tubulointerstitial injury in diabetic kidney disease.
    Jia Y; Xu H; Yu Q; Tan L; Xiong Z
    Bioengineered; 2021 Dec; 12(1):6655-6673. PubMed ID: 34506229
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tubulointerstitium as predictor of progression of glomerular diseases.
    D'Amico G
    Nephron; 1999; 83(4):289-95. PubMed ID: 10575289
    [No Abstract]   [Full Text] [Related]  

  • 80. Revisiting glomerular hyperfiltration and examining the concept of high dietary protein-related nephropathy in athletes and bodybuilders.
    Cho E; Choi SJ; Kang DH; Kalantar-Zadeh K; Ko GJ
    Curr Opin Nephrol Hypertens; 2022 Jan; 31(1):18-25. PubMed ID: 34846311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.